5 ways digital health, and digital pharma, changed in 2020Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, Share X5 ways digital health, and digital pharma, changed in 2020https://pharmaphorum.com/digital/digital-health-pharma-in-2020/
Biotech trends in COVID era: the pharmaphorum podcastIn episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently Share XBiotech trends in COVID era: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/biotech-trends-pharnext-david-solomon/
AI implementation for pharma and healthcareAbid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, Share XAI implementation for pharma and healthcarehttps://pharmaphorum.com/views-and-analysis/ai-implementation-for-pharma-and-healthcare/
MHRA looks to AI to hunt for COVID-19 vaccine side effectsThe UK drugs regulator has awarded a £1.5 million tender to a software company for an artificial intelligence Share XMHRA looks to AI to hunt for COVID-19 vaccine side effectshttps://pharmaphorum.com/news/mhra-looks-to-ai-to-hunt-for-covid-19-vaccine-side-effects/
BMS joins forces with insitro to develop neurodegenerative treatmentsinsitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies Share XBMS joins forces with insitro to develop neurodegenerative treatmentshttps://pharmaphorum.com/news/bms-joins-forces-with-insitro-to-develop-neurodegenerative-treatments/
Novartis launches digital health hub in CanadaNovartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for Share XNovartis launches digital health hub in Canadahttps://pharmaphorum.com/digital/novartis-launches-digital-health-hub-in-canada/
Rare diseases, repurposing and the role of AIIn the age of artificial intelligence, no trial data should be going to waste. Findacure’s Rick Thompson looks Share XRare diseases, repurposing and the role of AIhttps://pharmaphorum.com/r-d/views-analysis-r-d/rare-diseases-repurposing-and-the-role-of-ai/
AI tool looks to provide personalised COVID careMicrosoft and UK clinical AI company Sensyne Health will use their SENSE clinical algorithms to help provide more Share XAI tool looks to provide personalised COVID carehttps://pharmaphorum.com/news/ai-tool-looks-to-provide-personalised-covid-care/
Healx uses AI to find drugs for Angelman SyndromeThe UK-based AI technology company Healx has begun a partnership with the Foundation for Angelman Syndrome Therapeutics (FAST), Share XHealx uses AI to find drugs for Angelman Syndromehttps://pharmaphorum.com/news/healx-uses-ai-to-find-drugs-for-angelman-syndrome/
